MR Spectroscopy in Diagnosis and Neurological Decision-Making

ABSTRACT

One of the most prolific chemical and anatomical imaging techniques of recent decades, magnetic resonance imaging (MRI), includes the ability to noninvasively assess neurochemical changes with magnetic resonance spectroscopy (MRS). Practical concerns are paramount in applying MRS, such as what the manufacturer provides with a routine MRI scanner, what methods are well tolerated by patients, and what has proved most diagnostically productive over a 25 year span of preliminary exploration of the technology. In this review, the authors explain the technical and neurochemical aspects of MRS and critically discuss its clinical neuroimaging applications.

KEYWORDS

MRI - spectroscopy - metabolite - N-acetylaspartate - choline - creatine

REFERENCES

• 1 Danielsen E R, Ross B D. Magnetic Resonance Spectroscopy in Diagnosis of Neurological Diseases. New York; Marcel Dekker 2000
• 2 Gillard J, Waldman A, Barker P Clinical MR Neuroimaging. Cambridge, UK; Cambridge University Press 2005
• 3 Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain.  Anat Rec. 2001;  265 54-84
• 4 Lin A, Nguy C-H, Shic F et al.. Accumulation of methylsulfonylmethane (MSM) in the human brain: identification by magnetic resonance spectroscopy.  Toxicol Lett. 2001;  123 169-177
• 5 Hoevener J, Lin A, Tran T et al.. Neurospectroscopy will miss the boat—AGAIN: the need for universal standards and database. Proceedings of International Society for Magnetic Resonance in Medicine Germany; May 2007
• 6 Harris K, Lin A, Bhattacharya P et al.. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.  Adv Exp Med Biol. 2006;  576 263-273
• 7 Haseler L J, Arcinue E, Danielsen E R et al.. Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome.  Pediatrics. 1997;  99 4-14
• 8 Govindaraju V, Young K, Maudsley A A. Proton NMR chemical shifts and coupling constants for brain metabolites.  NMR Biomed. 2000;  13 129-153
• 9 Burtscher I M, Skagerberg G, Geijer B et al.. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings.  AJNR Am J Neuroradiol. 2000;  21 84-93
• 10 Hollingworth W, Medina L S, Lenkinski R E et al.. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.  AJNR Am J Neuroradiol. 2006;  27 1404-1411
• 11 Chernov M F, Hayashi M, Izawa M et al.. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.  Brain Tumor Pathol. 2006;  23 19-27
• 12 Schlemmer H P, Bachert P, Henze M et al.. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy.  Neuroradiology. 2002;  44 216-222
• 13 Hinchey J, Chaves C, Appignani B et al.. A reversible posterior leukoencephalopathy syndrome.  N Engl J Med. 1996;  334 494-500
• 14 Wang H C, Cheng S J. The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients.  J Neurol. 2003;  250 948-955
• 15 Lin A P, Tran T T, Ross B D. Impact of evidence-based medicine on magnetic resonance spectroscopy: clinical practice, reimbursement, and solutions.  NMR Biomed. 2006;  19 476-483
• 16 Clinical Policy Bulletin: Magnetic Resonance Spectroscopy (MRS). April 13, 2007. Available at: http://www.aetna.com/cpb/medical/data/200_299/0202.html Accessed January 2, 2008
• 17 De Stefano N, Filippi M, Miller D et al.. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.  Neurology. 2007;  69 1942-1952
• 18 Lin A, Shic F, Zapata M et al.. Magnetic resonance spectroscopy diagnosis of Alzheimer Disease: verification at autopsy.  Neurobiol Aging. 2002;  23 S465
• 19 Lin A, Enriquez C, Ross B D. 1H magnetic resonance spectroscopy detection of chromosomal defects in Alzheimer's disease and Down syndrome. Proceedings from 11th International Society for Magnetic Resonance in Medicine 2003
• 20 Godbolt A K, Waldman A D, MacManus D G et al.. MRS shows abnormalities before symptoms in familial Alzheimer disease.  Neurology. 2006;  66 718-722
• 21 Adalsteinsson E, Sullivan E V, Kleinhans N, Spielman D M, Pfefferbaum A. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.  Lancet. 2000;  355 1696-1697
• 22 Sailasuta N, Shriner K, Ross B. Evidence of decreased glutamate in the frontal lobe of HIV patients. Proceedings of the 15th Conference on Retroviruses and Opportunistic Infections Boston; 2008 Poster E-168
• 23 Patil S T, Zhang L, Martenyi F et al.. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.  Nat Med. 2007;  13 1102-1107
• 24 Weinberger D R. Schizophrenia drug says goodbye to dopamine.  Nat Med. 2007;  13 1018-1019
• 25 Blüml S, Moreno-Torres A, Shic F et al.. Tricarboxylic acid cycle of glia in the in vivo human brain.  NMR Biomed. 2002;  15 1-5
• 26 Harris K C, Bhattacharya P, Lin A P et al.. Apparent glutamate neurotransmitter rate is reduced in schizophrenic humans: a 1-13C glucose MRS study. Proceedings of the 21st Annual Scientific Meeting, ESMRMB 2004, Denmark Abstract 62:S31
• 27 Siddall P J, Stanwell P, Woodhouse A et al.. Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report.  Anesth Analg. 2006;  102 1164-1168
• 28 Somorjai R L, Dolenko B, Nikulin A K et al.. Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy.  J Magn Reson Imaging. 1996;  6 437-444
• 29 Bluml S, Kopyov O, Jacques S, Ross B D. Activation of neurotransplants in humans.  Exp Neurol. 1999;  158 121-125
• 30 Hoang T Q, Bluml S, Dubowitz D J et al.. Quantitative proton-decoupled ³¹P MRS and ¹H MRS in the evaluation of Huntington's and Parkinson's Diseases.  Neurology. 1998;  50 1033-1040
• 31 Ross B D. Long-term fetal cell transplant in Huntington disease: stayin' alive.  Neurology. 2008;  70 815-816
• 32 Manganas L N, Zhang X, Li Y et al.. Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain.  Science. 2007;  318 980-985
• 33 Stoica P, Sandgren N, Selen Y et al.. Frequency-domain method based on the singular value decomposition for frequency-selective NMR spectroscopy.  J Magn Reson. 2003;  165 80-88
• 34 Mekle1 R, Gruetter R. Comparison of a TEM head coil with an 8 channel head array coil at 3 Tesla. Proceedings from 14th International Society for Magnetic Resonance in Medicine 2006
• 35 Golman K, Ardenkjaer-Larsen J H, Petersson J S et al.. Molecular imaging with endogenous substances.  Proc Natl Acad Sci U S A. 2003;  100 10435-10439
• 36 Bhattacharya P, Harris K, Lin A et al.. Ultrafast three dimensional free precession imaging.  MAGMA. 2005;  18 245-256
• 37 Shic F, Lin A, Shelden C H et al.. Definition of the neurochemical patterns of human head injury in 1H MRS using wavelet analysis. Proceedings from 9th International Society for Magnetic Resonance in Medicine 2001
• 38 Provencher S W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra.  Magn Reson Med. 1993;  30 672-679